Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.

Kawaguchi Y, Miyamoto S, Hajika Y, Ashida N, Hirota T, Masumoto K, Sawa J, Hamazaki K, Kumeda Y

DOI: 10.1007/s12325-022-02138-w
Published: 2022 Jun
Container: Advances in therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12325-022-02138-w,
  title = {Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.},
  author = {Kawaguchi Y and Miyamoto S and Hajika Y and Ashida N and Hirota T and Masumoto K and Sawa J and Hamazaki K and Kumeda Y},
  year = {2022},
  journal = {Advances in therapy},
  doi = {10.1007/s12325-022-02138-w},
  url = {https://doi.org/10.1007/s12325-022-02138-w}
}

RIS

TY  - JOUR
TI  - Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.
AU  - Kawaguchi Y
AU  - Miyamoto S
AU  - Hajika Y
AU  - Ashida N
AU  - Hirota T
AU  - Masumoto K
AU  - Sawa J
AU  - Hamazaki K
AU  - Kumeda Y
PY  - 2022
JO  - Advances in therapy
DO  - 10.1007/s12325-022-02138-w
UR  - https://doi.org/10.1007/s12325-022-02138-w
ER  -

APA

Y, K., S, M., Y, H., N, A., T, H., K, M., J, S., K, H., & Y, K. (2022). Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.. Advances in therapy. https://doi.org/10.1007/s12325-022-02138-w

Source records

pubmed · retrieved 2026-09-25T21:49:28.335Z